| Your Resource for Neurotherapeutics Discovery and Development |
2026 Training in Neurotherapeutic Clinical Trials:
|
|
|
Learning Objectives
This 2-day course will introduce participants to the principles of neurotherapeutic clinical trial development and implementation. The course is relevant to anyone interested in effectively conducting neurotherapeutic clinical trials.
Students will learn:
The history of clinical trials
Present-day structure of clinical trials
Overview of preclinical and IND enabling studies
Best practices and processes for selecting sites and investigators
Steps required to ensure adequate assessment of safety and efficacy within Phase I and II
Design and implementation of multicenter trials in Phase III
Issues in drafting protocols and assessing adverse events
Practical aspects of managing Phase II and III data
Course Design
The course combines didactic lectures with active engagement activities in which the students will be challenged to utilize the lecture material during group workshops on protocol design and adverse events.
This course is designed to provide clinicians, scientists, and clinical research professionals with a knowledge base necessary to lead and conduct neurotherapeutic clinical trials.
Course Topics
Some of the topics covered in the course include:
Introduction and broad overview of the genesis of clinical trials and the protection of human participants
Present structure, with a focus on phases and types of trials, equipoise, oversight, and informed consent
Discovery, translation of novel mechanisms into a viable target for treatment, and toxicology studies
Process of obtaining investigational new drug and investigational device exemption status for clinical trials
Complexities of selecting sites and investigators
Phase I - safety, tolerability, pharmacokinetics, and pharmacodynamics
Phase II - demonstrating efficacy
Phase III - implementation of multicenter trials
Adverse Events - recognition, evaluation, and reporting
Critical elements of protocol design
Practical aspects of phase III data, including data capture and reporting
The course faculty consists of leaders in the field of neurotherapeutics in industry, academia, and government, with combined decades of experience in clinical trials. Participating faculty include:
Continuing Engagement Activities Following the Course
Students will be encouraged to connect with faculty mentors following the course. In an effort to facilitate these connections both students and faculty will have several opportunities to network during the ASENT Annual Meeting immediately following the course. These networking opportunities will help foster these connections to ensure they are lasting relationships that course participants can access in the future.
Course Venue
The 2026 offering of ASENT’s Clinical Trials Course will be held Monday, March 2 - Tuesday, March 3, 2026 at the Hyatt Regency Bethesda in Bethesda, Maryland. The course will be held in person only - no virtual option is available at this time.
Course Location
Hyatt Regency Bethesda, Bethesda, MD
Register
Download Course Brochure Register to Participate